title: Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
abstract: We have carried out SEREX (serological identification of antigens by recombinant cDNA expression cloning), and identified SLC2A1 (solute carrier family 2/facilitated glucose transporter, member 1) as an antigen recognized by serum IgG antibodies in patients with esophageal squamous cell carcinoma (SCC). The levels of serum anti-SLC2A1 antibodies (s-SLC2A1-Abs), examined by enzyme-linked immunosorbent assay using bacterially expressed glutathione-S-transferase-SLC2A1 fusion protein, were significantly higher in patients with esophageal SCC than in healthy donors. When using a cut-off level as the mean + 2x standard deviations of healthy donors, a total of 12 (21%) out of 57 SCC patients were revealed as positive for s-SLC2A1-Abs. The presence of s-SLC2A1-Abs was not associated with either clinicopathological factors or survival. Because s-SLC2A1-Abs were not associated with the positivity of other conventional serum markers, a combination assay of s-SLC2A1-Abs with these conventional serum markers may be useful for the diagnosis and monitoring of esophageal SCC.
authors.affiliation: Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chuo-ku, Chiba 260-8670, Japan.
authors.forename: Mari
authors.initials: M
authors.lastname: Kuboshima
authors.forename: Hideaki
authors.initials: H
authors.lastname: Shimada
authors.forename: Tian-Ling
authors.initials: TL
authors.lastname: Liu
authors.forename: Kazue
authors.initials: K
authors.lastname: Nakashima
authors.forename: Fumio
authors.initials: F
authors.lastname: Nomura
authors.forename: Masaki
authors.initials: M
authors.lastname: Takiguchi
authors.forename: Takaki
authors.initials: T
authors.lastname: Hiwasa
authors.forename: Takenori
authors.initials: T
authors.lastname: Ochiai
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000276:immunology* / Q000473:pathology; D004938:Esophageal Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology; D005260:Female; D051272:Glucose Transporter Type 1 / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging
chemical_list: D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D051272:Glucose Transporter Type 1; C495677:SLC2A1 protein, human